Abstract
Disease-associated impairment/dysfunction of stem cell populations is prominent in chronic metabolic and inflammatory diseases, such as type 2 diabetes mellitus (DM) where the multifunctional properties (viability, proliferation, paracrine secretion, multilineage differentiation) of bone marrow resident mesenchymal stem cells (MSCs) can be affected. The growth and viability impairments make it difficult to study the underlying molecular mechanisms related to the dysfunction of these cells in vitro. We have consequently optimized the isolation and culture conditions for impaired/dysfunctional bone marrow MSCs from B6.Cg-Lepob/J obese prediabetic mice. The method described here permits ex vivo investigations into disease-associated functional impairments and the dysregulated molecular mechanisms in these primary MSCs through direct comparisons with their healthy wild-type C57BL6/J control mouse counterparts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19(3):180–192
Morrison SJ, Scadden DT (2014) The bone marrow niche for haematopoietic stem cells. Nature 505(7843):327–334
Schatteman GC (2004) Adult bone marrow-derived hemangioblasts, endothelial cell progenitors, and EPCs. Curr Top Dev Biol 64:141–180
Polymeri A, Giannobile WV, Kaigler D (2016) Bone marrow stromal stem cells in tissue engineering and regenerative medicine. Horm Metab Res 48(11):700–713
Fijany A, Sayadi LR, Khoshab N, Banyard DA, Shaterian A, Alexander M et al (2019) Mesenchymal stem cell dysfunction in diabetes. Mol Biol Rep 46(1):1459–1475
Kornicka K, Houston J, Marycz K (2018) Dysfunction of mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use. Stem Cell Rev 14(3):337–345
van de Vyver M (2017) Intrinsic mesenchymal stem cell dysfunction in diabetes mellitus: implications for autologous cell therapy. Stem Cells Dev 26(14):1042–1053
Mangialardi G, Madeddu P (2016) Bone marrow-derived stem cells: a mixed blessing in the multifaceted world of diabetic complications. Curr Diab Rep 16(5):43. https://doi.org/10.1007/s11892-016-0730-x
van de Vyver M, Niesler C, Myburgh KH, Ferris WF (2016) Delayed wound healing and dysregulation of IL6/STAT3 signalling in MSCs derived from pre-diabetic obese mice. Mol Cell Endocrinol 426:1–10
Mehrbani Azar Y, Green R, Niesler CU, van de Vyver M (2018) Antioxidant preconditioning improves the paracrine responsiveness of bone marrow mesenchymal stem cells to diabetic wound fluid. Stem Cells Dev. https://doi.org/10.1089/scd.2018.0145
Tan J, Zhou L, Zhou Y et al (2017) The influence of diabetes mellitus on proliferation and osteoblastic differentiation of MSCs. Curr Stem Cell Res Ther 12(5):388–400
Bakopoulou A, Apatzidou D, Aggelidou E, Gousopoulou E, Leyhausen G, Volk J et al (2017) Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects “stemness” properties. Stem Cell Res Ther 8(1):247. https://doi.org/10.1186/s13287-017-0705-0
Briquet A, Dubois S, Bekaert S, Dolhet M, Beguin Y, Gothot A (2010) Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica 95(1):47–56
Lu L, Song H-F, Zhang W-G, Liu XQ, Zhu Q, Cheng XL et al (2012) Potential role of 20S proteasome in maintaining stem cell integrity of human bone marrow stromal cells in prolonged culture expansion. Biochem Biophys Res Commun 422(1):121–127
Vacanti V, Kong E, Suzuki G, Sato K, Canty JM, Lee T (2005) Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol 205(2):194–201
Jackson Laboratories Mouse strain 000632
Batt RA, Everard DM, Gillies G, Wilkinson M, Wilson CA, Yeo TA (1982) Investigation into the hypogonadism of the obese mouse (genotype Ob/Ob). J Reprod Fertil 64(2):363–371
Batt RA, Hambi M (1982) Development of the hypothermia in obese mice (genotype Ob/Ob). Int J Obes 6(4):391–397
Rath EA, Thenen SW (1980) Influence of age and genetic background on in vivo fatty acid synthesis in obese (Ob/Ob) mice. Biochim Biophys Acta 618:18–27
Dubuc PU (1976) The development of obesity, hyperinsulinemia, and hyperglycemia in Ob/Ob mice. Metab Clin Exp 25(1):1567–1574
Boozer CN, Mayer J (1976) Effects of long-term restricted insulin production in obese-hyperglycemic (genotype Ob/Ob) mice. Diabetologia 12(2):181–187
Ewart-Toland A, Mounzih K, Qiu J, Chehab FF (1999) Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140(2):732–738
Seitz O, Schürmann C, Hermes N, Müller E, Pfeilschifter J, Frank S et al (2010) Wound healing in mice with high-fat diet- or Ob gene-induced diabetes-obesity syndromes: a comparative study. Exp Diabetes Res 2010:476969. https://doi.org/10.1155/2010/476969
Yu WH, Kimura M, Walczewska A et al (1997) Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci U S A 94(3):1023–1028
Cameron CM, Kostyo JL, Adamafio NA, Dunbar JC (1987) Metabolic basis for the diabetogenic action of growth hormone in the obese (Ob/Ob) mouse. Endocrinology 120(4):1568–1575
Schultz MB, Sinclair DA (2016) When stem cells grow old: phenotypes and mechanisms of stem cell aging. Development 143(1):3–14
Sivula CP, Suckow MA (2018) Euthanasia. In: Weichbrod RH, Thompson GA, Norton JN (eds) Management of animal care and use programs in research, education, and testing, 2nd edn. CRC Press/Taylor & Francis, Boca Raton, FL. ISBN-10: 9781498748445
Acknowledgements
This research was supported by the National Research Foundation (NRF) of South Africa.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Mehrbani Azar, Y. et al. (2020). Model for Studying the Effects of Chronic Metabolic Disease on Endogenous Bone Marrow Stem Cell Populations. In: Guest, P. (eds) Clinical and Preclinical Models for Maximizing Healthspan. Methods in Molecular Biology, vol 2138. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0471-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0471-7_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0470-0
Online ISBN: 978-1-0716-0471-7
eBook Packages: Springer Protocols